具有非凡的NIRF/光声成像性能和光热瘤治疗功效的预先色剂
Liu Shi1,2, Zhenzhou Chen1,3, Jiaxin Ou1
1Guangdong Provincial Key Laboratory of New Drug Screening, NMPA Key Laboratory for Research and Evaluation of Drug Metabolism and Guangdong-Hong Kong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.
Acta pharmaceutica Sinica. B
|January 14, 2025
概括
这项研究引入了S-NBD,这是一种用于检测宫癌中的生物醇的新型双模式探针. 该探针可实现有效的光热疗法 (PTT),从而完全切除瘤而不会复发.
科学领域:
- 生物医学工程 生物医学工程
- 在瘤学瘤学.
- 医疗成像医学成像
背景情况:
- 宫癌对健康造成重大负担,需要超越传统手术和化疗的先进治疗方法.
- 现有的疗法往往会导致严重的副作用,导致需要针对性和不那么侵入性的方法.
- 光热疗法 (PTT) 为癌症治疗提供了一个有前途的替代方案,对健康组织的损害最小.
研究的目的:
- 开发一种新的双模式近红外光 (NIRF) /光声学 (PA) 探针,用于生物醇检测和PTT.
- 通过将生物醇检测与PTT集成来增强瘤向和最大限度地减少副作用.
- 评估该探针在宫癌诊断和治疗中的in vivo疗效.
主要方法:
- 开发一种基于二异相的双模式探头 (S-NBD),具有NIRF/PA功能.
- 探测器光学属性的表征,包括辐射波长和斯托克斯转移.
- 评估探针的光热转换效率和in vivo瘤切除疗效.
主要成果:
- S-NBD探测器显示出高发射波长 (838 nm) 和大斯托克斯转移 (178 nm) 以有效检测生物乙醇.
- 探测器显示光热转换效率高达67.1%.
- 使用探针进行激光照射,在体内实现了完全的宫瘤切除,没有复发.
结论:
- 开发的S-NBD探头是生物醇成像和子宫癌中PTT的开创性工具.
- 这种双模式探针提供了改进的瘤诊断和治疗能力.
- 将NIRF/PA成像与PTT整合,为妇科恶性瘤提供了一个新的治疗策略.
相关概念视频
Targeted Cancer Therapies
7.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.1K
Tumor Immunotherapy
2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K


